Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
ArrePath
United States
- Princeton, New Jersey
- 03/03/2022
- Seed
- $20,000,000
ArrePath is a biotech company discovering and developing new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies.
We apply world-class science and innovation in imaging and AI / ML technologies to identify and develop novel drugs to address global health issues.
Our advanced machine learning (ML) and imaging-based drug discovery platform enables a rapid and efficient identification of new drug classes with desired activity profiles and clinical utility, coupled with a deep understanding of mechanism of action at the outset of the discovery process.
- Industry Biotechnology Research
- Website https://arrepath.com/
- LinkedIn https://www.linkedin.com/company/arrepath/about/
Related People
Lloyd PayneFounder
United Kingdom -
Drug Discovery executive and leader, AMR and anti-infectives specialist, CEO at ArrePath Inc., a Princeton University spin-out biotech company combining ML- and imaging-technologies to discovery and develop new classes of anti-infectives.
Advisor to the Novo REPAIR Impact Fund and the AMR Action Fund.
Formerly Head of Anti-infectives at Evotec SE and founding CEO of specialist Anti-infectives company, Euprotec (founded 2008, built and successfully sold to Evotec, 2014).
Working with companies and organisations dedicated to the discovery and development of new anti-infective therapies and vaccines across multiple sectors, including Biotech, CRO, academia, Public-Private Partnerships, VC / Investors, and charities.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)